68 FR 130 pgs. 40685-40686 - Manufacturer of Controlled Substances; Notice of Application
Type: NOTICEVolume: 68Number: 130Pages: 40685 - 40686
FR document: [FR Doc. 03-17124 Filed 7-7-03; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 18, 2003, Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, PO Box 440, State College, Pennsylvania 16801, made renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic class of controlled substances listed below:
| Drug | Schedule |
|---|---|
| Methcathinone (1237) | I |
| N-Ethylamphetamine (1475) | I |
| N,N-Dimethylamphetamine (1480) | I |
| 4-Methylaminorex (cis isomer) (1590) | I |
| Lysergic acid diethylamide (7315) | I |
| Mescaline (7381) | I |
| 3,4-Methylenedioxyamphetamine (7400) | I |
| N-Hydroxy-3, 4-methylenedioxyamphetamine (7402) | I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) | I |
| 3/4-Methylenedioxymethamphetamine (7405) | I |
| N-Ethyl-1- phenylcyclohexylamine (7455) | I |
| 1-(1-Phenylcyclohexyl) pyrrolidine (7458) | I |
| 1-[1- (2-Thienyl) cyclohexyl] piperidine (7470) | I |
| Dihydromorphine (9145) | I |
| Normorphine (9313) | I |
| 1-Phenylcyclohexylamine (7460) | II |
| Phencyclidine (7471) | II |
| Phenylacetone (8501) | II |
| 1-Piperidinocyclohexanecarbonitrile (8603) | II |
| Cocaine (9041) | II |
| Codeine (9050) | II |
| Dihydrocodeine (9120) | II |
| Benzoylecgonine (9180) | II |
| Morphine (9300) | II |
| Noroxymorphone (9668) | II |
The firm plans to manufacture small quantities of the listed controlled substances for reference standards.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistance Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel (CCD) and must be filed no later than September 8, 2003.
Dated: June 20, 2003
Laura M. Nagel,
Deputy Assistance Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 03-17124 Filed 7-7-03; 8:45 am]
BILLING CODE 4410-09-M